Anxiety Disorders And Depression Treatment Market Size, Share & Trends Report

Anxiety Disorders And Depression Treatment Market Size, Share & Trends Analysis Report By Drug (Antidepressants, Anxiolytics, Anticonvulsants, & Others), By Indication, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-1-68038-731-5
Number of Report Pages: 120
Format: PDF, Horizon Databook

Historical Range: 2018 - 2023
Forecast Period: 2024 - 2030
Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
  1.2. Market Definitions
  1.3. Research Methodology
1.3.1. Information Procurement
  1.3.2. Information or Data Analysis
  1.3.3. Market Formulation & Data Visualization
  1.3.4. Data Validation & Publishing
  1.4. Research Scope and Assumptions
  1.4.1. List of Data Sources
Chapter 2. Executive Summary
  2.1. Market Outlook
  2.2. Segment Outlook
  2.3. Competitive Insights
Chapter 3. Anxiety Disorders and Depression Treatment Market Variables, Trends, & Scope
  3.1. Market Introduction/Lineage Outlook
  3.2. Market Size and Growth Prospects (USD Million)
  3.3. Market Dynamics
  3.3.1. Market Drivers Analysis
  3.3.2. Market Restraints Analysis
  3.4. Anxiety Disorders and Depression Treatment Market Variables Market Analysis Tools
  3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
  3.4.1.2. Bargaining power of the buyers
  3.4.1.3. Threats of substitution
  3.4.1.4. Threats from new entrants
  3.4.1.5. Competitive rivalry
  3.4.2. PESTEL Analysis
  3.4.2.1. Political landscape
  3.4.2.2. Economic and Social landscape
  3.4.2.3. Technological landscape
  3.4.2.4. Environmental landscape
  3.4.2.5. Legal landscape
Chapter 4. Anxiety Disorders and Depression Treatment Market Variables : Drugs Estimates & Trend Analysis
  4.1. Segment Dashboard
  4.2. Anxiety Disorders and Depression Treatment Market Variables Market: Solution Movement Analysis, USD Million, 2023 & 2030
  4.3. Antidepressants
  4.3.1. Antidepressants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  4.4. Anxiolytics
  4.4.1. Anxiolytics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.5. Anticonvulsants
  4.5.1. Anticonvulsants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.6. Noradrenergic Agents
  4.6.1. Noradrenergic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.7. Atypical Antipsychotics
  4.7.1. Atypical Antipsychotics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Anxiety Disorders and Depression Treatment Market : Indication Estimates & Trend Analysis
  5.1. Segment Dashboard
  5.2. Anxiety Disorders and Depression Treatment Market: Technology Movement Analysis, USD Million, 2023 & 2030
  5.3. Depression
  5.3.1. Depression Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  5.4. Anxiety
  5.4.1. Anxiety Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Anxiety Disorders and Depression Treatment Market : Distribution Channel Estimates & Trend Analysis
  6.1. Segment Dashboard
  6.2. Anxiety Disorders and Depression Treatment Market: End-user Movement Analysis, USD Million, 2023 & 2030
  6.3. Hospitals
  6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.4. Retail Pharmacies
  6.4.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.5. Online Pharmacies
  6.5.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Anxiety Disorders and Depression Treatment Market : Regional Estimates & Trend Analysis
  7.1. Anxiety Disorders and Depression Treatment Market Share, By Region, 2023 & 2030, USD Million
  7.2. North America
  7.2.1. North America Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.2.2. U.S.
  7.2.2.1. U.S. Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.2.3. Canada
  7.2.3.1. Canada Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.2.4. Mexico
  7.2.4.1. Mexico Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3. Europe
  7.3.1. Europe Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.2. UK
  7.3.2.1. UK Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.3. Germany
  7.3.3.1. Germany Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.4. France
  7.3.4.1. France Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4. Asia Pacific
  7.4.1. Asia Pacific Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.2. China
  7.4.2.1. China Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.3. Japan
  7.4.3.1. Japan Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.4. India
  7.4.4.1. India Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.5. South Korea
  7.4.5.1. South Korea Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.6. Australia
  7.4.6.1. Australia Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.5. Latin America
  7.5.1. Latin America Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.5.2. Brazil
  7.5.2.1. Brazil Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6. Middle East and Africa
  7.6.1. Middle East and Africa Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6.2. Saudi Arabia
  7.6.2.1. Saudi Arabia Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6.3. UAE
  7.6.3.1. UAE Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6.4. South Africa
  7.6.4.1. South Africa Anxiety Disorders and Depression Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
  8.1. Recent Developments & Impact Analysis by Key Market Participants
  8.2. Company Categorization
  8.3. Company Heat Map Analysis
  8.4. Company Profiles
  8.4.1. Pfizers Inc.
  8.4.1.1. Participant’s Overview
  8.4.1.2. Financial Performance
  8.4.1.3. Product Benchmarking
  8.4.1.4. Recent Developments/ Strategic Initiatives
  8.4.2. H. Lundbeck A/S
  8.4.2.1. Participant’s Overview
  8.4.2.2. Financial Performance
  8.4.2.3. Product Benchmarking
  8.4.2.4. Recent Developments/ Strategic Initiatives
  8.4.3. Glaxo SmithKline Pharmaceuticals Ltd.
  8.4.3.1. Participant’s Overview
  8.4.3.2. Financial Performance
  8.4.3.3. Product Benchmarking
  8.4.3.4. Recent Developments/ Strategic Initiatives
  8.4.4. Merck & Co., Inc.
  8.4.4.1. Participant’s Overview
  8.4.4.2. Financial Performance
  8.4.4.3. Product Benchmarking
  8.4.4.4. Recent Developments/ Strategic Initiatives
  8.4.5. Eli Lilly & Company
  8.4.5.1. Participant’s Overview
  8.4.5.2. Financial Performance
  8.4.5.3. Product Benchmarking
  8.4.5.4. Recent Developments/ Strategic Initiatives
  8.4.6. AstraZeneca
  8.4.6.1. Participant’s Overview
  8.4.6.2. Financial Performance
  8.4.6.3. Product Benchmarking
  8.4.6.4. Recent Developments/ Strategic Initiatives
  8.4.7. Bristol-Myers Squibb
  8.4.7.1. Participant’s Overview
  8.4.7.2. Financial Performance
  8.4.7.3. Product Benchmarking
  8.4.7.4. Recent Developments/ Strategic Initiatives
  8.4.8. Johnson & Johnson
  8.4.8.1. Participant’s Overview
  8.4.8.2. Financial Performance
  8.4.8.3. Product Benchmarking
  8.4.8.4. Recent Developments/ Strategic Initiatives
  8.4.9. AbbVie Inc.
  8.4.9.1. Participant’s Overview
  8.4.9.2. Financial Performance
  8.4.9.3. Product Benchmarking
  8.4.9.4. Recent Developments/ Strategic Initiatives
  8.4.10. Sanofi
  8.4.10.1. Participant’s Overview
  8.4.10.2. Financial Performance
  8.4.10.3. Product Benchmarking
  8.4.10.4. Recent Developments/ Strategic Initiatives

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.